Factors associated with prior testing for HIV, Syphilis, and Hepatitis B and C among transgender women and travestis in Brazil.
Humans
Cross-Sectional Studies
Brazil
/ epidemiology
Transgender Persons
/ statistics & numerical data
Female
Syphilis
/ diagnosis
Adult
Hepatitis B
/ diagnosis
Hepatitis C
/ diagnosis
HIV Infections
/ diagnosis
Male
Young Adult
Adolescent
Middle Aged
Socioeconomic Factors
Sociodemographic Factors
Risk Factors
Journal
Revista brasileira de epidemiologia = Brazilian journal of epidemiology
ISSN: 1980-5497
Titre abrégé: Rev Bras Epidemiol
Pays: Brazil
ID NLM: 100954576
Informations de publication
Date de publication:
2024
2024
Historique:
received:
04
10
2023
accepted:
03
01
2024
medline:
21
8
2024
pubmed:
21
8
2024
entrez:
21
8
2024
Statut:
epublish
Résumé
To investigate the prior testing for HIV, syphilis, hepatitis B (HBV), and hepatitis C (HCV) among transgender women and travestis (TGW) in five Brazilian cities and identify factors associated with each of these previous tests. This is a cross-sectional study with the recruitment of TGW through respondent-driven sampling (TransOdara Study). The investigated outcome variable was prior testing for HIV, syphilis, HBV, and HCV in the last 12 months. The association between sociodemographic and behavioral factors with the outcome was analyzed using a binomial logistic regression with mixed effects. Adjusted odds ratios (aOR) and 95% confidence intervals (CI95%) were estimated. The proportions of individuals with prior testing in the past year were as follows: 56.3% for HIV, 58.0% for syphilis, 42.1% for HBV, and 44.7% for HCV. Negative associations with prior testing were observed for individuals aged 35 years or older, whereas positive associations were found for those with high school education, those who experienced verbal or psychological violence in the last 12 months, and those who had commercial or casual partners in the last 6 months. There was low frequency of testing in the 12 months preceding the study for HIV, syphilis, HBV, and HCV compared to the guidelines established by the Ministry of Health. Expanding access to and engagement with healthcare and prevention services for TGW is an essential strategy in reducing the transmission chain of HIV and other sexually transmitted infections (STIs).
Identifiants
pubmed: 39166580
pii: S1415-790X2024000200406
doi: 10.1590/1980-549720240008.supl.1
pii:
doi:
Types de publication
Journal Article
Langues
eng
por
Sous-ensembles de citation
IM
Pagination
e240008.supl.1Références
Cad Saude Publica. 2019;35(4):e00111318
pubmed: 30994743
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S210-9
pubmed: 27429185
Int J Equity Health. 2014 Sep 27;13(1):81
pubmed: 25261275
Rev Bras Epidemiol. 2024 Jan 19;27:e240002
pubmed: 38265314
Lancet HIV. 2017 Apr;4(4):e169-e176
pubmed: 28188030
Lancet. 2016 Jul 23;388(10042):412-436
pubmed: 27323919
AIDS Behav. 2016 Dec;20(Suppl 3):371-378
pubmed: 27726036
Transgend Health. 2020 Jun 08;5(2):90-103
pubmed: 32656353
Medicine (Baltimore). 2018 May;97(1S Suppl 1):S16-S24
pubmed: 29794601
BMC Public Health. 2022 Nov 18;22(1):2120
pubmed: 36401261
Soc Sci Med. 2013 May;84:22-9
pubmed: 23517700
PLoS One. 2021 Dec 1;16(12):e0260063
pubmed: 34851961
PLoS One. 2013 Oct 29;8(10):e77113
pubmed: 24204750
Trop Med Infect Dis. 2022 Sep 27;7(10):
pubmed: 36288010
Transgend Health. 2019 Apr 05;4(1):107-117
pubmed: 30972370
BMC Infect Dis. 2020 Nov 16;20(1):851
pubmed: 33198672
Int J Equity Health. 2021 Sep 6;20(1):199
pubmed: 34488781
Curr Opin HIV AIDS. 2014 Mar;9(2):168-73
pubmed: 24322537
Soc Sci Med. 2015 Dec;147:222-31
pubmed: 26599625
PLoS One. 2019 Aug 15;14(8):e0221013
pubmed: 31415625
J Epidemiol Community Health. 2012 Oct;66 Suppl 2:ii42-48
pubmed: 22495772
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S91-3
pubmed: 21406995